Finally, our results suggest that acid ceramidase plays a critical role in the pathogenesis of GBA1-associated PD, identifying this enzyme as a potential therapeutic target for the treatment of GBA1-associated neurodegeneration and other disorders where there is an elevation of deacylated GSLs. This evidence concerns the gene ASAH1 and Parkinson disease.